Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127


Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas.

Gasparotto D, Polesel J, Marzotto A, Colladel R, Piccinin S, Modena P, Grizzo A, Sulfaro S, Serraino D, Barzan L, Doglioni C, Maestro R.

Oncotarget. 2011 Dec;2(12):1165-75.


Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.

Wang T, Li Y, Wang W, Tuerhanjiang A, Wu Z, Yang R, Yuan M, Ma D, Wang W, Wang S.

Hum Pathol. 2014 Sep;45(9):1839-46. doi: 10.1016/j.humpath.2014.05.001. Epub 2014 May 24.


TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.

Galván JA, Helbling M, Koelzer VH, Tschan MP, Berger MD, Hädrich M, Schnüriger B, Karamitopoulou E, Dawson H, Inderbitzin D, Lugli A, Zlobec I.

Oncotarget. 2015 Jan 20;6(2):874-85.


Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.

Way TD, Huang JT, Chou CH, Huang CH, Yang MH, Ho CT.

Eur J Cancer. 2014 Jan;50(2):366-78. doi: 10.1016/j.ejca.2013.09.025. Epub 2013 Oct 21.


Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.

Zhang J, Cheng Q, Zhou Y, Wang Y, Chen X.

Oral Oncol. 2013 Nov;49(11):1043-50. doi: 10.1016/j.oraloncology.2013.08.003. Epub 2013 Sep 13.


Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.

Toll A, Masferrer E, Hernández-Ruiz ME, Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J, Baró T, Casado B, Gandarillas A, Costa I, Mojal S, Peña R, de Herreros AG, García-Patos V, Pujol RM, Hernández-Muñoz I.

J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.


TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.

Kim YH, Kim G, Kwon CI, Kim JW, Park PW, Hahm KB.

Oncol Rep. 2014 Mar;31(3):1380-8. doi: 10.3892/or.2014.2970. Epub 2014 Jan 8.


Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.

Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.

J Cell Mol Med. 2011 Mar;15(3):691-700. doi: 10.1111/j.1582-4934.2010.01052.x.


Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.

Kim SH, Kim JM, Shin MH, Kim CW, Huang SM, Kang DW, Suh KS, Yi ES, Kim KH.

Histol Histopathol. 2012 May;27(5):581-91. doi: 10.14670/HH-27.581.


Significance of heterogeneous Twist2 expression in human breast cancers.

Mao Y, Zhang N, Xu J, Ding Z, Zong R, Liu Z.

PLoS One. 2012;7(10):e48178. doi: 10.1371/journal.pone.0048178. Epub 2012 Oct 25.


Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells.

Dennis M, Wang G, Luo J, Lin Y, Dohadwala M, Abemayor E, Elashoff DA, Sharma S, Dubinett SM, St John MA.

Otolaryngol Head Neck Surg. 2012 Oct;147(4):726-32. Epub 2012 May 7.


Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.

Li Y, Wang W, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D, Wang S.

Gynecol Oncol. 2012 Jan;124(1):112-8. doi: 10.1016/j.ygyno.2011.09.003. Epub 2011 Oct 22.


Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2.

Tang YL, Jiang J, Liu J, Zheng M, He YW, Chen W, Fan YL, Chen QM, Liao CH, Liang XH.

J Oral Pathol Med. 2015 May;44(5):337-44. doi: 10.1111/jop.12237. Epub 2014 Jul 22.


Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.

Liang X, Zheng M, Jiang J, Zhu G, Yang J, Tang Y.

Oral Oncol. 2011 Feb;47(2):92-7. doi: 10.1016/j.oraloncology.2010.11.014. Epub 2010 Dec 16.


EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.

Chang JW, Gwak SY, Shim GA, Liu L, Lim YC, Kim JM, Jung MG, Koo BS.

Oral Oncol. 2016 Jan;52:66-74. doi: 10.1016/j.oraloncology.2015.11.002. Epub 2015 Nov 18.


Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma.

Wang C, Liu X, Huang H, Ma H, Cai W, Hou J, Huang L, Dai Y, Yu T, Zhou X.

Int J Cancer. 2012 May 15;130(10):2249-58. doi: 10.1002/ijc.26226. Epub 2011 Aug 16.


The indicative function of Twist2 and E-cadherin in HPV oncogene-induced epithelial-mesenchymal transition of cervical cancer cells.

Liu Y, Qian W, Zhang J, Dong Y, Shi C, Liu Z, Wu S.

Oncol Rep. 2015 Feb;33(2):639-50. doi: 10.3892/or.2014.3620. Epub 2014 Nov 24.


Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck.

Kojc N, Zidar N, Gale N, Poljak M, Fujs Komlos K, Cardesa A, Höfler H, Becker KF.

Virchows Arch. 2009 May;454(5):549-55. doi: 10.1007/s00428-009-0771-5. Epub 2009 Apr 21.


Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Buehler D, Hardin H, Shan W, Montemayor-Garcia C, Rush PS, Asioli S, Chen H, Lloyd RV.

Mod Pathol. 2013 Jan;26(1):54-61. doi: 10.1038/modpathol.2012.137. Epub 2012 Aug 17.

Supplemental Content

Support Center